ONCOLOGÍA CLÍNICA

Foto de ONCOLOGÍA CLÍNICA

Foto de Hospital Duran i Reynals

Hospital Duran i Reynals

Barcelona, España

Publikationen in Zusammenarbeit mit Forschern von Hospital Duran i Reynals (5)

2024

First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328

2022

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Breast, Vol. 66, pp. 77-84

2020

Changes in lung cancer survival by TNM stage in the Basque country from 2003 to 2014 according to period of diagnosis
Cancer Epidemiology, Vol. 65

2013

Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. the large experience of the spanish national tumor registry (RGETNE)
Neuroendocrinology, Vol. 98, Núm. 2, pp. 156-168

2010

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)
Annals of Oncology, Vol. 21, Núm. 9, pp. 1794-1803